Sequenom +10.2% AH, receives European patent for detecting fetal aneuploidy

|By:, SA News Editor

Sequenom (SQNM) shares surge 10.2% in AH trading after the company announces it has received a patent for "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing" from the European Patent Office.

The company states that it is "the first patent filing made in the EPO directed to such novel methods."